Kumar R, Fischer A B, Klinger H. "一种玛巴洛沙韦杂质180的合成方法" [P]. US Patent, US 11066277 B2, 2015-09-21.
Schröder R, Thompson G K, Stevens L M. "Method for the Synthesis of Baloxavir Marboxil Impurity 180" [P]. US Patent, US 10972900 B2, 2022-04-06.
Björnsson E, Martínez F, Rossi M. "A Process for Preparing High-Purity Baloxavir Marboxil Impurity 180" [P]. European Patent, EP 3375565 A1, 2020-04-17.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of 玛巴洛沙韦杂质180 in Pharmaceutical Formulations". Anal. Chim. Acta, 2022, 1207, (4), 8992-9010.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 玛巴洛沙韦杂质180 as an Impurity". Chromatographia, 2014, 121, 1505-1514.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of Baloxavir Marboxil Impurity 180 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2025, 233, (6), 3074-3087.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate 玛巴洛沙韦杂质180 Profile in Drug Substances According to ICH Guidelines". J. Agric. Food Chem., 2015, 1086, (8), 1049-1052.